Saturday 13 December 2014

New Proteasome Inhibitor Targets Myeloma (CME/CE)

(MedPage Today) -- Objective responses occurred in 25% to 30% of pretreated patients. via MedPageToday.com - medical news plus CME for physicians Read More Here..
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)